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Botulinum neurotoxins are produced by the anaerobic bacterium Clostridium botulinum and are 
divided into seven distinct serotypes (A to G) known to cause botulism in animals and humans. In this 
study, a multiplexed quantitative real-time PCR assay for the simultaneous detection of the human 
pathogenic C. botulinum serotypes A, B, E, and F was developed. Based on the TaqMan chemistry, 
we used five individual primer-probe sets within one PCR, combining both minor groove binder- and 
locked nucleic acid-containing probes. Each hydrolysis probe was individually labeled with 
distinguishable fluorochromes, thus enabling discrimination between the serotypes A, B, E, and F. To 
avoid false-negative results, we designed an internal amplification control, which was simultaneously 
amplified with the four target genes, thus yielding a pentaplexed PCR approach with 95% detection 
probabilities between 7 and 287 genome equivalents per PCR. In addition, we developed six individual 
singleplex real-time PCR assays based on the TaqMan chemistry for the detection of the C. botulinum 
serotypes A, B, C, D, E, and F. Upon analysis of 42 C. botulinum and 57 non-C. botulinum strains, the 
singleplex and multiplex PCR assays showed an excellent specificity. Using spiked food samples we 
were able to detect between 103 and 105 CFU/ml, respectively. Furthermore, we were able to detect C. 
botulinum in samples from several cases of botulism in Germany. Overall, the pentaplexed assay 
showed high sensitivity and specificity and allowed for the simultaneous screening and differentiation 
of specimens for C. botulinum A, B, E, and F. 
 
Botulinum neurotoxins (BoNTs), the causative agents of botulism, are produced by the anaerobic 
bacterium Clostridium botulinum and are divided into seven serotypes, A to G. While the botulinum 
neurotoxins BoNT/A, BoNT/B, BoNT/E, and BoNT/F are known to cause botulism in humans, BoNT/C 
and BoNT/D are frequently associated with botulism in cattle and birds. Despite its toxicity, BoNT/G 
has not yet been linked to naturally occurring botulism (26).  
 
Botulism is a life-threatening illness caused by food contaminated with BoNT (food-borne botulism), by 
the uptake and growth of C. botulinum in wounds (wound botulism), or by colonization of the intestinal 
tract (infant botulism) (14). In addition, C. botulinum and the botulinum neurotoxins are regarded as 
potential biological warfare agents (8).  
 
The gold standard for the detection of BoNTs from food or clinical samples is still the mouse lethality 
assay, which is highly sensitive but rather time-consuming. In addition to various immunological 
assays for BoNT detection, several conventional and real-time PCR-based assays for the individual 
detection of bont genes have been reported (2, 9–12, 15, 20, 23, 27–30). A major improvement is the 
simultaneous detection of more than one serotype, which results in a reduction of effort and in the 
materials used. In recent years, both conventional and real-time PCR-based multiplex assays have 
been developed for the simultaneous detection of C. botulinum serotypes (1, 6, 22, 24). To date, 
  
however, no internally controlled multiplex real-time PCR assay for the simultaneous detection and 
differentiation of all four serotypes relevant for humans has been reported.  
 
We describe here a highly specific and sensitive multiplex real-time PCR assay based on the 5’-
nuclease TaqMan chemistry (17) for the simultaneous detection of the C. botulinum types A, B, E, and 
F, including an internal amplification control (IAC). Furthermore, we developed six different singleplex 
assays based on the TaqMan chemistry for the detection of C. botulinum serotypes A to F. Assays 
were validated on 42 C. botulinum strains, 57 non-C. botulinum strains, on spiked food samples, and 
on real samples from cases of botulism in Germany.  
 
 
Materials and Methods 
 
Bacterial strains and culture conditions.  
The bacterial strains used in the present study are listed in Table 1. Clostridial strains were cultured in 
reinforced clostridia medium (RCM; Sifin, Berlin, Germany) or in tryptone-peptone-glucose- yeast 
(TPGY) broth for 3 days in an anaerobic workstation (Don Whitley Scientific, Ltd., West Yorkshire, 
United Kingdom). The titer of the C. botulinum strains 2292 (serotype A), 1029 (serotype B), 1032 
(serotype E), and 1033 (serotype F) was determined on blood agar plates. One milliliter of 10-fold 
dilutions of the cultures was spread on blood agar plates, and colonies were counted after 24 h of 




PCR primers and probes.  
The primers and probes used here are given in Table 2. Primers and probes were based on the 
published DNA sequences from GenBank database (http://www.ncbi.nih.gov/GenBank/) for the 
neurotoxin genes bont/a, bont/b, bont/c, bont/d, bont/e, and bont/f (Table 2). All primers and LNA 
probes were obtained from TIB Molbiol (Berlin, Germany) or Sigma-Aldrich (Munich, Germany); MGB 
probes were obtained from Applied Biosystems (Foster City, CA). 
 
 
Standard plasmids and internal amplification control.  
As positive controls and for evaluation of the real-time PCR assays, plasmids containing the PCR 
target regions pBoNT/A, pBoNT/B, pBoNT/C, pBoNT/D, pBoNT/E, and pBoNT/F were constructed. 
The amplicon for each real-time PCR was amplified by conventional PCR using the same primers as 
for the TaqMan PCR (Table 2). Amplicons were cloned into pCR2.1-TOPO vectors and used for the 
transformation of TOP10 cells (both from Invitrogen, Karlsruhe, Germany), according to the 
manufacturer’s instructions. Serial dilutions of the plasmids were prepared in H2O (Roth, Karlsruhe, 
Germany) supplemented with 100 μg of salmon-sperm DNA (AppliChem, Darmstadt, Germany)/ml 
and stored at -20°C until use.  
 
The plasmid pKoMa2 was used as an IAC for the real-time PCRs. The IAC consists of a chemically 
synthesized DNA sequence (Table 2) containing the target sequence for the primers KoMa_F and 
KoMa_R and the probes KoMa_TM or KoMa_TS (Table 2) cloned into the pPCR-Script vector 
(Stratagene, La Jolla, CA).  
 
 
Real-time PCR assays.  
All real-time PCRs were performed on the LightCycler 480 II system in a total volume of 20 μl using a 
white LightCycler 480 Multiwell Plate 96 covered with adhesive sealing foil (Roche, Mannheim, 
Germany). Thermal cycling was done with a two-step PCR protocol: activation of the Taq DNA 
polymerase at 95°C for 15 min, followed by 45 cycles of 95°C for 15 s and 60°C for 40 s. The 
fluorescence data were collected at the end of every 60°C step, and runs were analyzed using 
LightCycler 480 software (Roche). All real-time PCRs were performed as duplicates. Primer and 
probes used for singleplex and multiplex PCR are listed in Table 2. (i) The multiplex reaction mix 
contained 2 μl of template; 10 μl of 2 x ABsolute QPCR mix (ABgene, Epsom, United Kingdom); and 
optimized concentrations of primer and probes for C. botulinum serotypes A, B, E, and F and KoMa2 
(Table 2). Also, 75 copies of pKoMa2, as an IAC, were added to a total volume of 20 μl of H2O. (ii) The 
singleplex reactions contained 2 μl of template, 10 μl of 2 x ABsolute QPCR mix, optimized 
  
concentrations of primer and probes for C. botulinum serotypes A to F (Table 2), and H2O added to a 
final volume of 20 μl. 
 
 
Standard curves and PCR performance.  
To determine the performance of the different real-time PCR assays, standard curves were obtained 
by amplification of 10-fold dilutions of the standard plasmids. The obtained threshold cycles (CT) were 
plotted against the logarithm of copy number. Analyses were done using the Prism 5.0 Software 
(GraphPad, La Jolla, CA). The PCR efficiency (E) of the multiplex and singleplex assays was 
calculated according to the formula E = 10(-1/slope) -1 (21).  
 
 
Detection limit.  
The detection probability for the standard plasmids was determined by multiplex and singleplex PCR, 
analyzing serial dilutions of the standard plasmids pBoNT/A, pBoNT/B, pBoNT/E, or pBoNT/F. The 
95% detection probability was calculated with Prism 5.0, using the cumulative Gaussian distribution 
model (Table 3). 
 
 
Preparation of spiked food samples.  
Food samples (vacuum-packed, gilled, smoked mackerel; frozen green beans; vacuum-packed, 
smoked black pudding with meat) used in the present study were purchased from a local retail shop 
and stored at -20°C until use. Food samples were homogenized in stomacher bags with an equal 
volume of gelatin-phosphate buffer (0.2% [wt/vol] gelatin in 28mM Na2HPO4 [pH 6.2]) using a 
BagMixer (Interscience, Saint Nom la Bretèche, France). Each homogenate was spiked with 106, 105, 
104, or 103 CFU of C. botulinum serotype A (strain 2292), C. botulinum serotype B (strain 1029), C. 
botulinum serotype E (strain 1032), or C. botulinum serotype F (strain 1033)/ml, respectively. 
 
 
DNA extraction.  
Genomic DNA from bacterial culture was purified with the DNeasy blood and tissue kit (Qiagen, 
Hilden, Germany) according to the manufacturer’s instructions. DNA extraction from spiked food 
samples (Table 4) or real botulism specimens (Table 5) was performed with the DNeasy blood and 
tissue kit using a modified protocol. After centrifugation (10 min, 7,500 x g) of 200 μl of the spiked food 
slurry, the sediment was dissolved in 180 μl of lysis buffer (20 mM Tris-HCl [pH 8.0], 2 mM EDTA, 
1.2% [vol/vol] Triton X-100, 20 mg of lysozyme/ml) and lysed for 30 min at 37°C. After the addition of 
25 μl of proteinase K (600 mAU/ml; Qiagen) and 180 μl of ATL buffer (Qiagen), the lysate was 
incubated for 30 min at 56°C, followed by 15 min at 95°C. The following steps were performed 
according to the manufacturer’s instructions for the purification of DNA from animal tissue. The purified 
template DNA was eluted twice with 50 μl of AE buffer (Qiagen).  
 
 
Investigation of suspected samples.  
Suspected samples of three cases of human food-borne botulism (cases 1, 2, and 3), one case of 
infant botulism (case 4), and two cases of animal botulism, one in cattle (case 5) and one in ducks 
(case 6), were analyzed by TaqMan PCR (Table 5). The specimens were collected between 2006 and 
2009 in Germany. Suspected specimens were transmitted to our laboratory by the relevant German 
state institutions for food, drug and epizooties, namely, the Landeslabor Brandenburg (case 1), the 
Landesamt für Verbraucherschutz Sachsen-Anhalt (case 3) or the Institut für Lebensmittel, 
Arzneimittel, und Tierseuchen in Berlin (cases 2, 5, and 6), respectively. Samples from case 4 
originated from the Children’s Hospital of the Charité (Berlin, Germany). For enrichment cultures, 5 ml 
of TPGY broth and/or cooked meat medium (Oxoid, Hampshire, United Kingdom) were inoculated with 
500 μl of homogenized samples and incubated anaerobically at 28°C and/or 37°C for 3 to 5 days. 
After DNA extraction, real-time multiplex and singleplex assays were performed in two independent 










Real-time PCR amplification performance.  
Starting with singleplex real-time PCR approaches, we developed individual assays for the 
amplification of bont/a, bont/b, bont/c, bont/d, bont/e, and bont/f using MGB containing oligoprobes 
(Table 2). Amplification performances of singleplex real-time PCR were determined from the standard 
curves of the BoNT standard plasmids. As shown in Fig. 1, all real-time PCR assays showed a strong 
linear correlation (R2 > 0.99) between the CT value and the template concentration over a range of 5 
orders of magnitude.  
 
In order to develop a multiplex assay for the simultaneous amplification of bont/a, bont/b, bont/e, and 
bont/f, together with an IAC, it was necessary, for some of the target genes, to select TaqMan probes 
different from that of the singleplex assays. It was also necessary to include both MGB 
oligonucleotides and LNA oligonucleotides in order to increase the annealing temperature and to 
shorten the probe length (Table 2). The oligoprobes were labeled with different reporter dyes (Cy5, 
VIC, FAM, TEX, and Cyan500) and were cross validated with the respective forward and reverse 
primers in a multiplex approach (data not shown). For each bont amplicon, the oligoprobes were 
tested either coupled to an MGB moiety or modified with LNA bases, and additionally with one of the 
four different colors Cy5, VIC, FAM, or TEX. The optimal MGB-containing or LNA-containing 
oligoprobes were selected for each bont amplicon and finally, the quadruplex assay for bont/a, bont/b, 
bont/e, and bont/f was combined with the IAC assay (i.e., the presence of 75 copies of the synthetic 
sequence IAC, plasmid pKoMa2). The optimal primer-probe sets for the final pentaplexed approach 
are given in Table 2. As shown in Fig. 1 for the simultaneous amplification of bont/a, bont/b, bont/e, 
and bont/f, together with IAC, the performances of the multiplex assay and the respective singleplex 
assays were almost identical. The slopes for both the multiplex and the singleplex assays ranged from 
-3.889 to -3.243, resulting in PCR efficiencies of 97.9% versus 90.3%, 96.2% versus 92.9%, 103.4% 
versus 93.8%, and 90.6% versus 88.6%, respectively, for the multiplex versus singleplex assays for 
bont/a, bont/b, bont/e, and bont/f. In addition, the fluorescence spectra of the different reporter dyes 
used in the multiplex assay were well separated and showed no spectral overlap (data not shown). 
 
 
Specificity of real-time PCRs.  
The specificity of primers and probes was evaluated in silico against the published sequences from the 
GenBank database using the BLAST algorithm. Primer and probe sets were selected to allow 
amplification of all subtypes of serotypes known thus far: A1, A2, A3, A4, and A5; B1, B2, B3, 
nonproteolytic B, and bivalent B; E1, E2, E3, E4, E5, and E6; F baratii, F proteolytic, F nonproteolytic, 
and F bivalent; and C and D, including C/D and D/C mosaic types. To confirm the in silico results, we 
analyzed 42 C. botulinum strains and 57 non-C. botulinum strains with the singleplex and multiplex 
real-time PCR assays (Table 1). The multiplex realtime PCR for the simultaneous detection of bont/a, 
bont/b, bont/e, and bont/f showed a high specificity for the predicted target. A total of 4 of the 42 tested 
C. botulinum strains (REB1750, NCTC 2916, NCTC 11199, and NCTC 12265) tested positive for two 
BoNT genes. As expected, the nontoxic (as determined by mouse assay) C. botulinum A strain 2276 
and all of the C. botulinum C and D strains revealed no PCR signal in the multiplex PCR specific for 
bont/a, bont/b, bont/e, and bont/f.  
 
Similarly, each of the six singleplex real-time PCR was only positive for the predicted target. Strains 
2276, 1030, 2141, 2145, and 1739, which had been originally reported to contain the bont gene, gave 
negative results in the six singleplex reactions. The absence of the bont genes in these cultures was 
confirmed by mouse assay. Neither the multiplex PCR nor the singleplex PCR analyses of the non-C. 
botulinum strains was positive for the bont genes.  
 
 
Detection limits of multiplex and singleplex PCR.  
To define the sensitivity of the multiplex real-time PCR, we determined the detection probability for 
different copy numbers between 6 and 800 copies of the standard plasmids in the presence of 75 
copies of the IAC pKoMa2. The 95% detection probability per reaction analyzed with the multiplex 
assay was 32.5 copies for pBoNT/A, 7.4 copies for pBoNT/B, 24.0 copies for pBoNT/E, and 287.2 
copies for pBoNT/F (Table 3).  
 
  
The obtained detection probabilities of 95% for the standard plasmids analyzed with the singleplex 
PCR were 31.6 copies for pBoNT/A, 7.4 copies for pBoNT/B, 6.4 copies for pBoNT/C, 6.9 copies for 
pBoNT/D, 16.8 copies for pBoNT/E, and 122.4 copies for pBoNT/F per reaction (Table 3). 
 
 
Detection of C. botulinum from spiked food samples.  
We tested the sensitivity of the multiplex PCR assay directly from food samples without prior 
enrichment by anaerobic culture. We spiked three different food samples (black pudding, green beans, 
and smoked mackerel) with 10-fold serial dilutions of C. botulinum serotypes A, B, E, and F (103 to 106 
CFU/ml), extracted the DNA, and performed the multiplex PCR assay as described above. The 
detection limits for C. botulinum serotypes A, B, E, and F in smoked mackerel were 105, 103, 104, and 
104 CFU/ml, respectively (Table 4). These detection limits correspond to 400 bacterial cells per PCR 
of C. botulinum serotype A, 4 cells per PCR for C. botulinum serotype B, and 40 cells per PCR for C. 
botulinum serotypes E and F. In green beans and black pudding, we were able to detect as little as 
104 CFU of C. botulinum serotype A/ml, 103 CFU of C. botulinum serotypes B and E/ml, and 104 CFU 
of C. botulinum serotype F/ml (Table 4). This corresponds to detection limits of 40 cells per PCR for C. 
botulinum serotypes A and F, and 4 cells per PCR for C. botulinum serotypes B and E. All C. 
botulinumnegative samples returned positive signals specific for the IAC pKoMa2. In addition, we were 
also able to detect C. botulinum serotypes A, B, E, and F directly from the spiked green beans and 
black pudding, without previous DNA extraction (data not shown). 
 
 
Investigation of suspected samples.  
In order to test the multiplex and singleplex real-time PCR assays on real specimens, we analyzed six 
suspected food, four stool, and several tissue samples from six different cases of botulism in Germany 
(Table 5). All analyses were performed both on DNA extracted directly from the specimens, without 
prior anaerobic culture or any other enrichment step, and after enrichment by anaerobic culture. The 
suspected home-cured ham (case 1), the home-made green bean salad (case 2), and home-
marinated herring and one stool sample from case 3 tested positive for BoNT/B, BoNT/A, and BoNT/E, 
respectively, by both multiplex and singleplex PCRs. The stool sample from a case of infant botulism 
(case 4) prior to antibiotic treatment returned a positive result for C. botulinum serotype A. However, 
stool specimens taken a week later, after antibiotic treatment, were negative. All tissue specimens 
from a cow with botulism symptoms (case 5) gave positive results in the singleplex PCR for C. 
botulinum serotype D. Specimens from a symptomless control animal were negative. In gut and liver 
specimens from three perished ducks taken during an outbreak of avian botulism (case 6) BoNT/C 
was identified. All samples that were positive for bont gave positive results without and after 
enrichment (Table 5), except for the frozen herring (case 3), which tested positive only after 
enrichment by anaerobic culture, both with the real-time PCR and in the mouse bioassay. In addition, 
all of the tested samples demonstrated positive results for the IAC, thus confirming the absence of 
PCR inhibitors in the extracted DNA. All PCR results were confirmed by mouse bioassays performed 
at the Robert Koch-Institut, at the Landeslabor Brandenburg (Frankfurt/Oder, Germany) or the Institut 





In the present study we developed a pentaplexed real-time PCR assay for the simultaneous detection 
and quantification of bont/a, bont/b, bont/e, and bont/f, including an internal control IAC in comparison 
to singleplex real-time PCR assays for all relevant bont target genes. We analyzed the assay 
performance, specificity, and sensitivity and validated the PCR approaches with differently spiked food 
samples and with specimens from several cases of botulism.  
 
While the detection of single BoNT genes by conventional or real-time PCR methods is well 
established, a number of PCR assays for the detection of three or more BoNT genes have also been 
described (11, 13, 15, 23, 27, 28, 29). More recent work has complemented these studies by the 
description and validation of a conventional multiplex approach for the simultaneous detection of all 
four human pathogenic bont genes (6, 22). Previous approaches have used degenerated primers to 
detect more than one BoNT gene. Similarly, our pentaplexed PCR assay uses degenerate primers to 
accommodate sequence variations within the specific binding regions of bont genes and therefore is 
able to detect all human pathogenic serotypes and subtypes described thus far (A1, A2, A3, A4, and 
A5; B1, B2, B3, nonproteolytic B, and bivalent B; E1, E2, E3, E4, E5, and E6; F baratii, proteolytic F, 
  
nonproteolytic F, and bivalent F) (5, 7, 16). In addition, the pentaplexed PCR approach correctly 
identifies a novel A subtype identified in our group in the context of a recent food-borne botulism case 
(strain Chemnitz, Table 1 and also unpublished results).  
 
Generally, major advantages of the real-time TaqMan approach compared to the conventional PCR 
approach (using gel separation of amplified targets) include the increased assay specificity (by a third 
gene-specific oligoprobe), reduced assay time (online detection of amplification products, no 
electrophoresis step), and ease of quantification (using defined concentrations of standard plasmids). 
From a technical perspective, multiplexing a real-time PCR for more than four target genes is 
challenging for a number of reasons. (i) To date, only a few instruments are able to detect and 
differentiate more than four different fluorescent reporter dyes, among them the LightCycler 480 II 
used in the present study. (ii) An increase in the number of primers and probes per PCR at the same 
time enhances the problem of nonspecific oligonucleotide interactions. Therefore, shorter 
oligonucleotides with good hybridiza- tion performance are necessary. For this purpose, alternative 
probe chemistries have been introduced, such as MGB- and LNA-containing oligoprobes (19). (iii) 
Some of these improved oligoprobes can only be purchased coupled to a limited number of 
fluorescent dyes (e.g., MGB-containing probes can be purchased only with up to three different 
reporter dyes).  
 
To our knowledge, the present study is one of the first to describe a multiplex real-time PCR approach 
that combines both MGB- and LNA-containing oligoprobes within one reaction. Our study describes 
only the second reported use of a pentaplexed real-time PCR assay, following a recent description of 
a pentaplexed assay for the simultaneous quantification of respiratory RNA viruses (25). While setting 
up our pentaplexed assay, we empirically learned that mixing of MGB- and LNA-containing 
oligoprobes rendered a superior PCR performance, compared to a multiplex assay with LNA probes 
only. For each target gene, we carefully selected the optimal probe chemistry (MGB or LNA) and 
reporter dye (Cy5, VIC, FAM, TEX, and Cyan500) in order to obtain concordant results for the 
pentaplex approach and the optimal singleplex reaction. In the final pentaplexed assay, both the 
specificity and the sensitivity were equivalent to the singleplex approach: analysis of 42 C. botulinum 
strains and 57 non-C. botulinum strains using the designed multiplex and singleplex real-time PCR 
assays showed high specificity for their predicted target, with no observed cross-reactivity.  
 
With respect to the analysis of clinical, environmental, or food samples, the use of an internal 
amplification control is mandatory for any diagnostic PCR method. An internally controlled PCR would 
demonstrate failure of the assay, e.g., due to the presence of PCR inhibitors in the complex sample 
material, and therefore avoids false-negative results (18). Consequently, the use of an IAC is included 
in different international standards, e.g., in ISO 22174, for the analysis of food. Among all PCR assays 
published on the detection of C. botulinum, however, only a limited number include the use of an IAC 
(1, 3, 6, 24). In our pentaplexed PCR approach, the IAC based on a synthetic sequence was 
simultaneously amplified with the target sequences bont/a, bont/b, bont/e, and bont/f. In order to avoid 
competition between the bont-specific and the IAC-specific amplification, the IAC plasmid pKoMa2 
was optimally used at a low concentration (75 copies per reaction). In our description of the multiplex 
approach, we followed almost all of the recently defined MIQE guidelines for real-time PCR 
experiments which serve to standardize experimental practice and to promote consistency between 
laboratories (4).  
 
When we tested the sensitivity of the multiplex PCR assay with C. botulinum A, B, E, and F spiked into 
different food, we found a limit of detection of 103 to 105 CFU/ml directly from the spiked food samples, 
without prior enrichment by anaerobic culture. In addition, we successfully applied the multiplex and 
singleplex real-time PCR assays to specimens from cases of food-borne, infant, and animal botulism 
(different food, feces, and different organs). Samples that tested positive for C. botulinum by mouse 
bioassay concordantly tested positive by our multiplex and singleplex assays. With one exception, the 
multiplex and singleplex real-time PCR worked with DNA directly extracted from the suspicious 
specimens, without prior anaerobic culture, thus yielding results faster than the mouse bioassay. 
Nevertheless, the independent enrichment step by anaerobic culture is recommended for cases where 
low concentrations of bacteria are present.  
 
Advancing the existing PCR-based detection of BoNT-producing clostridia, the present study 
describes a pentaplexed real-time PCR assay for the simultaneous detection of bont/a, bont/b, bont/e, 
and bont/f, including an IAC. Of technical interest is the successful combination of both MGB- and 
LNAcontaining oligoprobes in the current pentaplex approach. The multiplex assay was found to be as 
sensitive and specific as the independently developed and validated singleplex real-time PCR assays 
  
for all relevant bont genes. Furthermore, the pentaplex assay allows the detection, differentiation, and 
quantification of all serotypes and subtypes associated with human botulism known thus far, including 
a novel A subtype identified recently in our group. Most importantly, the assay turned out to be very 
robust and rapid when analyzing food and clinical specimens from cases of botulism. Therefore, this 
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Tables and Figures  
 







a *, nontoxic C. botulinum strains according to mouse bioassay. 
b NCTC, National Collection of Type Culture, London, United Kingdom; Göttingen, Miprolab 
Mikrobiologische Diagnostik, Göttingen, Germany; TLLV, Thüringer Landesamt für 
Lebensmittelsicherheit und Veterinärmedizin, Bad Langensalza, Germany; Leipzig, Konsiliarlabor für 
Anaerobe Bakterien, Leipzig, Germany; RKI, Robert Koch-Institut, Berlin, Germany. †, strains kindly 
provided by U. Nübel, Robert Koch-Institut, Wernigerode, Germany. 
c In the multiplex approach, bont/a, bont/b, bont/e, and bont/f were simultaneously amplified together 
with IAC. Isolates producing the toxins C and D were used here as negative controls. In the singleplex 
approach, the respective individual bont genes were tested for comparison. A, B, C, D, E, or F, 
specific PCR signal for bont/a, bont/b, bont/c, bont/d, bont/e, or bont/f, respectively. –, no PCR signal 





























aGenBank accession numbers: bont/a, AY327854; bont/b, AB084152; bont/c, D49440; bont/d, 
X54254; bont/e, AB040128; bont/f, X81714. 
b BBQ, BlackBerry Quencher; BHQ, Black Hole Quencher; FAM, 6’-carboxyfluorescein; MGB, minor 
groove binder; NFQ, nonfluorescent quencher; TEX, Texas Red; boldfaced nucleotides denote locked 
nucleic acid (LNA) bases. Nucleotide acronyms: M, A/C; R, A/G; S, G/C; Y, C/T. The IAC synthetic 








TGGC (the underlined nucleotides denote the priming sites for the primers KoMa_F and KoMa_R and 
the probes KoMa_TM or KoMa_TS). 
c S, sense orientation; A, antisense orientation. 
dM, multiplex real-time PCR; S, singleplex real-time PCR as indicated in Materials and Methods. In 
independent experiments, individual singleplex real-time PCRs gave identical results in the presence 
or absence of 75 copies of the synthetic gene IAC and the probe KoMa_TM, where KoMa_TS was 
used as depicted with Cy5 as a reporter dye and BBQ as a quencher. 


















a Tests were performed using the corresponding standard plasmids pBoNT/A, pBoNT/B, pBoNT/C, 
pBoNT/D, pBoNT/E, or pBoNT/F, respectively. 
b That is, the number of positive results/number of replicates tested. 


























a The strains used were strain 2292 (C. botulinum serotype A), strain 1029 (C. botulinum serotype B), 
strain 1032 (C. botulinum serotype E), and strain 1033 (C. botulinum serotype F). 
b A, B, E, or F, PCR signal for bont/a, bont/b, bont/e, or bont/f, respectively; –, no PCR signal for 
bont/a, bont/b, bont/e, or bont/f. The samples were analyzed in two independent PCR experiments 




































a Both multiplex and singleplex real-time PCR assays were performed on the indicated specimens. 
“Without enrichment” refers to PCR analysis of DNA directly extracted from the specimen; “after 
enrichment” refers to PCR analysis of DNA extracted from specimens after 3 to 5 days of anaerobic 
culture. A, B, D, or E indicates a positive PCR signal for bont/a, bont/b, bont/d, or bont/e, respectively; 
–, no PCR signal for bont/a, bont/b, bont/c, bont/d, bont/e, or bont/f. The samples were analyzed in 
two independent PCR experiments each, yielding the same results. The results were confirmed by 
mouse bioassay performed at the Robert Koch-Institut (Berlin, Germany; cases 3 and 4), Landeslabor 
Brandenburg (Frankfurt/Oder, Germany; case 1), or Institut für Lebensmittel, Arzneimittel und 
Tierseuchen (Berlin, Germany; cases 2, 5, and 6). 















Figure 1. Multiplex and singleplex real-time PCR standard curves. Logarithms of the copy numbers 
are plotted against their corresponding threshold cycles (CT). Multiplex PCR standard curves as 
measured in duplicates are shown as closed squares (■), and singleplex PCR standard curves are 
shown as open squares (□). The amplifications of pBoNT/A (A), pBoNT/B (B), pBoNT/C (C), pBoNT/D 
(D), pBoNT/E (E), and pBoNT/F (F) by singleplex and/or multiplex PCRs are shown. R2, regression 
correlation coefficient. 
 
 
 
  
